In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), CDC announces the following meeting for the aforementioned subcommittee.
Times and dates: 1 p.m.-5:30 p.m., August 9, 2007. 8:30 a.m.-3:30 p.m., August 10, 2007.
Place: CDC, 1825 Century Center, Conference Room 1 A/B, Atlanta, GA 30345.
Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 75 people. To accommodate public participation in the meeting, a conference telephone line will be available. The public is welcome to participate during the public comment periods by calling (866) 919-3560 and entering code 4168828. The public comment periods are tentatively scheduled from 4:45 p.m.-5 p.m. on August 9, 2007 and from 3 p.m.-3:15 p.m. on August 10, 2007.
Purpose: The Ethics Subcommittee will provide counsel to the ACD, CDC regarding a broad range of public health ethics questions and issues arising from programs, scientists, and practitioners.
Matters To Be Discussed: Agenda items will include: Ethical Guidance for Public Health Emergency Preparedness and Response, Ethical Issues relating to CDC Partnerships, Public Health Ethics and Genomics, Ethical Guidance for Non-Research Data Collections, and Updates on Ethical Issues relating to Pandemic Influenza Preparedness. Agenda items are subject to change as priorities dictate.
For security reasons, members of the public interested in attending the meeting should contact the person below. The deadline for notification of attendance is August 2, 2007.
Contact Person for More Information: Drue Barrett, Ph.D., Designated Federal Official, Ethics Subcommittee, CDC, 1600 Clifton Road, NE., M/S D-50, Atlanta, Georgia 30333. Telephone (404) 639-4690. E-mail: firstname.lastname@example.org.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.Start Signature
Dated: July 5, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office Centers for Disease Control and Prevention (CDC).
[FR Doc. E7-13523 Filed 7-11-07; 8:45 am]
BILLING CODE 4163-18-P